Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Polymorphisms of miR-196a2 (rs11614913) and miR-605 (rs2043556) confer susceptibility to gastric cancer

Full text
Poltronieri-Oliveira, Ayla Blanco [1] ; Madeira, Fernanda Fernandez [1] ; Santos Marques Nunes, Denis Bruno [1] ; Rodrigues, Gabriela Helena [1] ; Lopes, Beatriz Camargo [1] ; Manoel-Caetano, Fernanda S. [1] ; Biselli, Joice Matos [1] ; Silva, Ana Elizabete [1]
Total Authors: 8
[1] Univ Estadual Paulista, UNESP, Dept Biol, Cytogenet & Mol Biol Lab, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP - Brazil
Total Affiliations: 1
Document type: Journal article
Source: GENE REPORTS; v. 7, p. 154-163, JUN 2017.
Web of Science Citations: 6

Background and purpose: MicroRNAs (miRNAs) have been appointed as potential biomarkers for gastric cancer. Recent evidences suggest that single-nucleotide polymorphisms (SNPs) in miRNAs may change the miRNA biogenesis and influence cancer susceptibility. The aim of this study was to investigate the association of Mir-SNPs in miR-27a rs895819, miR-125a rs12976445, miR-196a2 rs11614913, miR-499 rs3746444, and miR-605 rs2043556 and their effect, alone and combined, on gastric cancer risk. Methods: DNA samples obtained from 151 gastric cancer (GC) patients and 249 non-cancer subjects (control) were genotyped using the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) technique or the TaqMan (R) SNP Genotyping Assay. Multiple logistic regression analysis was used to assess the associations between the miRNA polymorphisms and GC risk according to log-additive, dominant, and recessive models. Combined genotype analyses were also performed, using Fisher's exact test. Results: The Mir-SNPs miR-27a rs895819, miR-125a rs12976445 and miR-499 rs3746444 were not associated with risk of GC. However, the miR-196a2 rs11614913 TT variant genotype was associated with a significantly increased risk for GC in the recessive model (OR = 2.88; 95% CI = 1.45-5.72; P = 0.002), and miR-605 rs2043556 AG and GG genotype carriers showed a significantly higher risk for GC in both the dominant (adjusted OR = 1.79; 95% CI = 1.14-2.82; P = 0.001) and the log-additive models (OR = 1.46; 95% CI = 1.01-2.12; P = 0.044). The combined genotype analysis showed that the presence of the three risk genotypes miR-27a G/miR-125a C/miR-605 G is associated with higher risk of GC (OR = 11.00; 95% CI = 1.13-106.5; P = 0.046). In addition, the combined genotype analysis of only miR-196a2 rs11614913 and miR-605 rs2043556 revealed that individuals carrying both risk alleles (miR-196a2 T/miR-605 G) also presented a significantly higher risk for GC compared to double wild-type homozygous individuals (OR = 2.00; 95% CI = 1.08-3.71; P = 0.031). Conclusions: Our data showed that miR-196a2 rs11614913 and miR-605 rs2043556, alone or in combination, modulate the risk of developing GC in a Brazilian population, and that the combined genotypes miR-27a G/miR125a C/miR-605 G may potentiate this risk. (AU)

FAPESP's process: 12/15036-8 - Evaluation of gene and protein expression in inflammatory processes and neoplasms of the digestive tract: stomach and colorectal
Grantee:Ana Elizabete Silva
Support type: Regular Research Grants